%0 Journal Article
%T Improving Antibiotic Prescribing for Children with Community-acquired Pneumonia in Outpatient Settings.
%A Daley MF
%A Reifler LM
%A Sterrett AT
%A Poole NM
%A Winn DB
%A Steiner JF
%A Arnold Rehring SM
%J J Pediatr
%V 274
%N 0
%D 2024 Jun 17
%M 38897380
%F 6.314
%R 10.1016/j.jpeds.2024.114155
%X <B>OBJECTIVE: </B>To assess whether a two-phase intervention was associated with improvements in antibiotic prescribing among nonhospitalized children with community-acquired pneumonia.<BR><B>METHODS: </B>In a large health care organization, a first intervention phase was implemented in September 2020 directed at antibiotic choice and duration for children 2 months through 17 years of age with pneumonia. Activities included clinician education and implementation of a pneumonia-specific order set in the electronic health record. In October 2021, a second phase comprised additional education and order set revisions. A narrow spectrum antibiotic (eg, amoxicillin) was recommended in most circumstances. Electronic health record data were used to identify pneumonia cases and antibiotics ordered. Using interrupted time series analyses, antibiotic choice and duration after phase one (September 2020-September 2021) and after phase two (October 2021-October 2022) were compared with a preintervention prepandemic period (January 2016-early March 2020).<BR><B>RESULTS: </B>Overall, 3570 cases of community-acquired pneumonia were identified: 3246 cases preintervention, 98 post-phase one, and 226 post-phase two. The proportion receiving narrow spectrum monotherapy increased from 40.6% preintervention to 68.4% post-phase one to 69.0% post-phase two (P < .001). For children with an initial narrow spectrum antibiotic, duration decreased from preintervention (mean duration 9.9 days, SD 0.5 days) to post-phase one (mean 8.2, SD 1.9) to post-phase two (mean 6.8, SD 2.3) periods (P < .001).<BR><B>CONCLUSIONS: </B>A two-phase intervention with educational sessions combined with clinical decision support was associated with sustained improvements in antibiotic choice and duration among children with community-acquired pneumonia.